EE9900470A - Tsinkhüaluronaadi kasutamine peptilise haavandi vastu - Google Patents

Tsinkhüaluronaadi kasutamine peptilise haavandi vastu

Info

Publication number
EE9900470A
EE9900470A EEP199900470A EEP9900470A EE9900470A EE 9900470 A EE9900470 A EE 9900470A EE P199900470 A EEP199900470 A EE P199900470A EE P9900470 A EEP9900470 A EE P9900470A EE 9900470 A EE9900470 A EE 9900470A
Authority
EE
Estonia
Prior art keywords
peptic ulcer
zinc hyaluronate
against peptic
hyaluronate against
zinc
Prior art date
Application number
EEP199900470A
Other languages
English (en)
Inventor
Szporny L�szl� (surnud)
Ill�s J�nos
Mat�z Judit
Neszm�lyi Erzs�bet
Forrai G�born�
Zs�ka Erika
Stefk� B�la
S�ghy Katalin
Original Assignee
Richter Gedeon Vegy�Szeti Gy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegy�Szeti Gy�R Rt. filed Critical Richter Gedeon Vegy�Szeti Gy�R Rt.
Publication of EE9900470A publication Critical patent/EE9900470A/et
Publication of EE04953B1 publication Critical patent/EE04953B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900470A 1997-04-29 1998-04-28 Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks EE04953B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
PCT/HU1998/000044 WO1998048815A1 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer

Publications (2)

Publication Number Publication Date
EE9900470A true EE9900470A (et) 2000-06-15
EE04953B1 EE04953B1 (et) 2008-02-15

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900470A EE04953B1 (et) 1997-04-29 1998-04-28 Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks

Country Status (26)

Country Link
US (1) US6656921B1 (et)
EP (1) EP1017403B1 (et)
JP (1) JP2001522361A (et)
KR (1) KR100572190B1 (et)
CN (1) CN1126548C (et)
AT (1) ATE320814T1 (et)
BG (1) BG64458B1 (et)
BR (1) BR9809354A (et)
CA (1) CA2286756C (et)
CZ (1) CZ297317B6 (et)
DE (1) DE69833937T2 (et)
DK (1) DK1017403T3 (et)
EA (1) EA002134B1 (et)
EE (1) EE04953B1 (et)
ES (1) ES2259813T3 (et)
HU (1) HU225991B1 (et)
IL (1) IL132214A0 (et)
NO (1) NO328313B1 (et)
NZ (1) NZ500978A (et)
PL (1) PL189526B1 (et)
PT (1) PT1017403E (et)
SK (1) SK284864B6 (et)
TW (1) TW501927B (et)
UA (1) UA62964C2 (et)
WO (1) WO1998048815A1 (et)
ZA (1) ZA983626B (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
US8057294B2 (en) * 2005-09-09 2011-11-15 Wms Gaming Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
WO2013129577A1 (ja) * 2012-03-01 2013-09-06 キユーピー株式会社 TGF-β発現促進経口剤、痛み物質産生抑制経口剤及び浮腫抑制経口剤
WO2015076294A1 (ja) * 2013-11-22 2015-05-28 キユーピー株式会社 薬剤の副作用である胃潰瘍の発症抑制方法、および胃潰瘍発症が抑制された経口薬剤組成物ならびにその製造方法
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
AU600483B2 (en) * 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
JPH0648950A (ja) 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Also Published As

Publication number Publication date
EP1017403A1 (en) 2000-07-12
DK1017403T3 (da) 2006-07-31
ZA983626B (en) 1998-11-05
SK284864B6 (sk) 2006-01-05
US6656921B1 (en) 2003-12-02
KR100572190B1 (ko) 2006-04-18
WO1998048815A1 (en) 1998-11-05
CA2286756C (en) 2008-02-19
CA2286756A1 (en) 1998-11-05
CZ382799A3 (cs) 2000-03-15
HU225991B1 (en) 2008-02-28
NO995229D0 (no) 1999-10-26
SK146899A3 (en) 2000-06-12
HUP9700826A1 (hu) 1998-12-28
BG103822A (en) 2000-04-28
PL336482A1 (en) 2000-06-19
DE69833937D1 (de) 2006-05-11
CN1254285A (zh) 2000-05-24
ATE320814T1 (de) 2006-04-15
IL132214A0 (en) 2001-03-19
CN1126548C (zh) 2003-11-05
NO328313B1 (no) 2010-01-25
ES2259813T3 (es) 2006-10-16
EE04953B1 (et) 2008-02-15
NZ500978A (en) 2001-05-25
KR20010020413A (ko) 2001-03-15
EA002134B1 (ru) 2001-12-24
EA199900983A1 (ru) 2000-08-28
DE69833937T2 (de) 2007-06-06
CZ297317B6 (cs) 2006-11-15
BR9809354A (pt) 2000-07-04
HU9700826D0 (en) 1997-06-30
UA62964C2 (en) 2004-01-15
PT1017403E (pt) 2006-07-31
PL189526B1 (pl) 2005-08-31
EP1017403B1 (en) 2006-03-22
BG64458B1 (bg) 2005-03-31
JP2001522361A (ja) 2001-11-13
NO995229L (no) 1999-12-22
HK1025250A1 (en) 2000-11-10
TW501927B (en) 2002-09-11

Similar Documents

Publication Publication Date Title
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
FI970810A0 (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
DE69735963D1 (de) Aminoalkohole enthaltende ophthalmische Zusammensetzungen
MY130477A (en) Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
BG102667A (en) Diosgenine-containing composition
GB9505082D0 (en) Medicament
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
AU2811400A (en) Stable formulation containing fumagillin
BG104258A (en) 4-cyano-4-deformylsordarin derivatives

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231